Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Syntaxin 1 is a component of the 7S and 20S SNARE complexes which are involved in docking and fusion of synaptic vesicles with the presynaptic plasma membrane. Additionally we are shipping STXBP5 Proteins (3) and many more products for this protein.
Showing 4 out of 4 products:
Human Monoclonal STXBP5 Primary Antibody for BI, IF - ABIN968460
Fujita, Shirataki, Sakisaka, Asakura, Ohya, Kotani, Yokoyama, Nishioka, Matsuura, Mizoguchi, Scheller, Takai: Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process. in Neuron 1998
Show all 2 references for ABIN968460
Human Polyclonal STXBP5 Primary Antibody for ICC, WB - ABIN1742382
Burgalossi, Jung, Meyer, Jockusch, Jahn, Taschenberger, OConnor, Nishiki, Takahashi, Brose, Rhee: SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. in Neuron 2010
Genetic variations in STXBP5 and CLEC4M (show CLEC4M Antibodies) are associated with VWF (show VWF Antibodies) level variation in type 1, but not in type 2 von Willebrand disease.
STXBP5 is required for normal arterial hemostasis, due to its contributions to platelet granule cargo packaging and secretion
STXBP5 inhibits endothelial exocytosis and promotes platelet secretion
Identify 3 loci associated with circulating tPA (show PLAT Antibodies) levels, the PLAT (show PLAT Antibodies) region, STXBP5, and STX2 (show STX2 Antibodies). Functional studies implicate a novel role for STXBP5 and STX2 (show STX2 Antibodies) in regulating tPA (show PLAT Antibodies) release.
Genetic variation in STXBP5 is associated with bleeding phenotype in female type 1 von Willebrand Disease patients.
Genetic variation in STXBP5 gene is associated with venous thrombosis.
multiple domains outside the R-SNARE (show YKT6 Antibodies) of tomosyn are critical to the efficacy of inhibition by tomosyn on exocytotic secretion
Genetic variability in STXBP5 and STX2 (show STX2 Antibodies) affects both VWF (show VWF Antibodies) concentration and activity in young individuals with premature arterial thrombosis.
PIASgamma-dependent modification of tomosyn-1 with SUMO-2 (show SUMO2 Antibodies)/3 presents a novel mechanism to adapt secretory strength to the dynamic synaptic environment.
regulates SNARE (show VTI1B Antibodies) complex formation and synaptic vesicle fusion. (review)
Interacts with SNAP23 (show SNAP23 Antibodies) and Syntaxin4 (show STX4 Antibodies) and plays a role in Insulin (show INS Antibodies)-stimulated GLUT4 (show SLC2A4 Antibodies) translocacion.
The interaction between syntaxin4 (show STX4 Antibodies) and Munc18c (show STXBP3 Antibodies) in adipocytes results in enhancement of insulin (show INS Antibodies)-stimulated GLUT4 (show SLC2A4 Antibodies) externalization.
In the pancreatic beta-cell, tomosyn negatively regulates insulin (show INS Antibodies) exocytosis.
Tomosyn-1 is involved in a post-docking event that prepares secretory granules for fusion and is necessary to sustain exocytosis of pancreatic beta-cells in response to insulin (show INS Antibodies) secretagogues.
Tomosyn inhibits neurotransmitter release by catalyzing oligomerization of the SNARE (show VTI1B Antibodies) complex through the N-terminal WD-40 repeat domain in addition to the inhibitory activity of the C-terminal (VAMP (show VAMP Antibodies))-like domain.
Syntaxin 1 is a component of the 7S and 20S SNARE complexes which are involved in docking and fusion of synaptic vesicles with the presynaptic plasma membrane. This gene encodes a syntaxin 1 binding protein. In rat, a similar protein dissociates syntaxin 1 from the Munc18/n-Sec1/rbSec1 complex to form a 10S complex, an intermediate which can be converted to the 7S SNARE complex. Thus this protein is thought to be involved in neurotransmitter release by stimulating SNARE complex formation. Alternatively spliced transcript variants encoding different isoforms have been identified.
lethal(2) giant larvae protein homolog 3
, putative protein product of Nbla04300
, syntaxin-binding protein 5
, tomosyn 1